Cancer BiologybioRxivPreprint
CLM296: a highly selective inhibitor targeting ALDH1A3-driven tumor growth and metastasis in breast cancer
Maya R. MacLean, Bianca Laura Bernardoni, Wasundara Fernando…·Paola Marcato
This paper introduces CLM296, a highly selective ALDH1A3 inhibitor that reduces tumor growth and metastasis in TNBC xenografts with favorable pharmacokinetics and safety profile.
DOI 10.1101/2025.04.16.649105